Ashland pharmaceuticals

Ashland webinar:
reimagining cyclodextrins – a series on advanced delivery innovations


view on demand

Improving solubility and enhancing stabilization can pose significant challenges in drug development. Early-stage identification of the most suitable approach among a diverse set of methodologies is crucial for drug improvement. With continuous advancements in pharmaceutical formulation, this series looks to examine the use of cyclodextrins for parenteral excipients, and the novel ways in which these can be leveraged. 

In this series, we will explore innovations in cyclodextrin use, such as cell cultures, microspheres, and disaccharide formulations. This initial webinar will provide the foundation upon which we build for future sessions, including discussions on: 

  • types of cyclodextrins and variations of importance
  • Ashland portfolio of cyclodextrins 
  • important physical chemical and biological properties of cyclodextrins for parenteral administration  
  • principles of drug-cyclodextrin complex formation 
  • regulatory overview and considerations for safe parenteral administration 
  • rational step-by-step approach to optimize drug solubilization and stabilization in parenteral formulations  

Register for the webinar replay today to learn about the innovative ways in which cyclodextrins are being used in pharmaceutical formulation and delivery.

presenter information:

Cory Mahnen
parenteral and bioprocessing senior team leader Ashland

Cory Mahnen is a graduate of Kent State University, with a Master of Science in biology. He currently leads the parenteral and biopharma R&D teams at Ashland. With more than a decade of experience working in complex parenteral product and process development, his focus is primarily on long-acting injectables (LAIs) utilizing PLGA in the form of nanoparticles, microparticles and in situ depots. Cory can be contacted at cory.mahnen@ashland.com.

 

 

Spencer Bouhadir
director of research and development
Leuvian

Spencer Bouhadir is an accomplished chemist with a robust background in formulation chemistry and biochemistry, dedicated to advancing scientific innovation across diverse applications. With more than a decade of applied training, his expertise spans the development of cell culture media, wound care solutions, and advanced drug delivery systems, consistently turning theoretical concepts into efficacious realities. With a passion for solving complex challenges, he drives progress in health and biotechnology through rigorous research and creative problem solving. Spencer can be contacted at spencer@cascadebiosciences.com.

 

register for webinar replay

Fill out the form to view or download our recent webinar..

By checking the subscribe box and submitting this form, I agree to my email address being stored and used to receive promotional emails from Ashland, and I acknowledge that I have read and understand the Ashland privacy policy.